CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS
China
201880073043.9
Filed on 2018-11-07
201880073043.9
Filed on 2018-11-07
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy
US Patent 11,453,719
Filed on 2019-09-30
Filed on 2019-09-30
Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development
US Patent 10,844,128
Filed on 2019-09-20
Filed on 2019-09-20
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY
Patent Cooperation Treaty
PCT/US2019/052226
Filed on 2019-09-20
PCT/US2019/052226
Filed on 2019-09-20
PEPTIDE HYDROGELS AND USE THEREOF
US Patent 11,661,439
Filed on 2020-06-16
Filed on 2020-06-16
M971 CHIMERIC ANTIGEN RECEPTORS
US Patent 11,807,682
Filed on 2020-05-08
Filed on 2020-05-08
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3
Israel
274003
Filed on 2020-04-16
274003
Filed on 2020-04-16
USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS
US Patent 11,351,185
Filed on 2020-03-11
Filed on 2020-03-11